Annual total expenses:
$453.25M+$18.13M(+4.17%)Summary
- As of today (June 3, 2025), BCRX annual total expenses is $453.25 million, with the most recent change of +$18.13 million (+4.17%) on December 31, 2024.
- During the last 3 years, BCRX annual total expenses has risen by +$118.36 million (+35.34%).
- BCRX annual total expenses is now at all-time high.
Performance
BCRX Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$124.31M-$11.73M(-8.63%)Summary
- As of today (June 3, 2025), BCRX quarterly total expenses is $124.31 million, with the most recent change of -$11.73 million (-8.63%) on March 31, 2025.
- Over the past year, BCRX quarterly total expenses has increased by +$17.06 million (+15.91%).
- BCRX quarterly total expenses is now -8.65% below its all-time high of $136.07 million, reached on December 31, 2023.
Performance
BCRX Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
BCRX Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.2% | +15.9% |
| 3 y3 years | +35.3% | +24.5% |
| 5 y5 years | +205.7% | +171.4% |
BCRX Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +35.3% | -8.7% | +33.3% |
| 5 y | 5-year | at high | +205.7% | -8.7% | +200.4% |
| alltime | all time | at high | +5943.4% | -8.7% | +7669.2% |
BCRX Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $124.31M(-8.6%) |
| Dec 2024 | $453.25M(+4.2%) | $136.04M(+24.4%) |
| Sep 2024 | - | $109.39M(+8.8%) |
| Jun 2024 | - | $100.57M(-6.2%) |
| Mar 2024 | - | $107.25M(-21.2%) |
| Dec 2023 | $435.12M(+3.8%) | $136.07M(+37.9%) |
| Sep 2023 | - | $98.66M(-4.4%) |
| Jun 2023 | - | $103.19M(+6.2%) |
| Mar 2023 | - | $97.19M(-22.8%) |
| Dec 2022 | $419.26M(+25.2%) | $125.86M(+34.9%) |
| Sep 2022 | - | $93.27M(-7.0%) |
| Jun 2022 | - | $100.25M(+0.4%) |
| Mar 2022 | - | $99.88M(+0.5%) |
| Dec 2021 | $334.89M(+73.9%) | $99.33M(+16.1%) |
| Sep 2021 | - | $85.58M(+7.6%) |
| Jun 2021 | - | $79.54M(+12.9%) |
| Mar 2021 | - | $70.44M(+24.8%) |
| Dec 2020 | $192.57M(+29.9%) | $56.42M(+15.2%) |
| Sep 2020 | - | $48.97M(+18.3%) |
| Jun 2020 | - | $41.38M(-9.7%) |
| Mar 2020 | - | $45.80M(+15.0%) |
| Dec 2019 | $148.29M(+29.1%) | $39.83M(+8.0%) |
| Sep 2019 | - | $36.87M(+1.4%) |
| Jun 2019 | - | $36.37M(+3.3%) |
| Mar 2019 | - | $35.22M(+25.8%) |
| Dec 2018 | $114.87M(+39.1%) | $27.99M(-6.5%) |
| Sep 2018 | - | $29.95M(-2.6%) |
| Jun 2018 | - | $30.75M(+17.4%) |
| Mar 2018 | - | $26.19M(+20.4%) |
| Dec 2017 | $82.60M(+10.2%) | $21.75M(-1.6%) |
| Sep 2017 | - | $22.11M(+18.8%) |
| Jun 2017 | - | $18.61M(-7.5%) |
| Mar 2017 | - | $20.12M(+17.2%) |
| Dec 2016 | $74.96M(-14.5%) | $17.17M(+1.0%) |
| Sep 2016 | - | $17.00M(+0.5%) |
| Jun 2016 | - | $16.92M(-29.1%) |
| Mar 2016 | - | $23.87M(+9.5%) |
| Dec 2015 | $87.70M(+47.7%) | $21.80M(-9.7%) |
| Sep 2015 | - | $24.15M(+17.8%) |
| Jun 2015 | - | $20.50M(-3.6%) |
| Mar 2015 | - | $21.26M(+3.2%) |
| Dec 2014 | $59.38M(+23.6%) | $20.60M(+38.8%) |
| Sep 2014 | - | $14.85M(+13.5%) |
| Jun 2014 | - | $13.09M(+20.7%) |
| Mar 2014 | - | $10.84M(-35.8%) |
| Dec 2013 | $48.05M(-17.8%) | $16.90M(+81.5%) |
| Sep 2013 | - | $9.31M(-28.1%) |
| Jun 2013 | - | $12.96M(+46.1%) |
| Mar 2013 | - | $8.87M(-32.0%) |
| Dec 2012 | $58.42M(-15.6%) | $13.04M(-5.4%) |
| Sep 2012 | - | $13.78M(-4.2%) |
| Jun 2012 | - | $14.39M(-16.5%) |
| Mar 2012 | - | $17.22M(+5.9%) |
| Dec 2011 | $69.23M(-27.7%) | $16.27M(-9.9%) |
| Sep 2011 | - | $18.05M(+0.4%) |
| Jun 2011 | - | $17.98M(+6.2%) |
| Mar 2011 | - | $16.93M(-34.8%) |
| Dec 2010 | $95.70M(+8.4%) | $25.97M(+13.0%) |
| Sep 2010 | - | $22.99M(+28.1%) |
| Jun 2010 | - | $17.95M(-37.7%) |
| Mar 2010 | - | $28.80M(-27.7%) |
| Dec 2009 | $88.33M | $39.81M(+87.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2009 | - | $21.25M(+57.1%) |
| Jun 2009 | - | $13.53M(-1.6%) |
| Mar 2009 | - | $13.75M(-43.7%) |
| Dec 2008 | $83.73M(-19.1%) | $24.44M(+32.3%) |
| Sep 2008 | - | $18.47M(+15.1%) |
| Jun 2008 | - | $16.04M(-35.3%) |
| Mar 2008 | - | $24.78M(-21.6%) |
| Dec 2007 | $103.52M(+94.6%) | $31.60M(-2.2%) |
| Sep 2007 | - | $32.33M(+53.7%) |
| Jun 2007 | - | $21.03M(+108.2%) |
| Mar 2007 | - | $10.10M(-21.3%) |
| Dec 2006 | $53.19M(+94.6%) | $12.83M(-29.7%) |
| Sep 2006 | - | $18.25M(+45.1%) |
| Jun 2006 | - | $12.57M(+31.8%) |
| Mar 2006 | - | $9.54M(+27.0%) |
| Dec 2005 | $27.33M(+23.7%) | $7.51M(-5.7%) |
| Sep 2005 | - | $7.96M(+32.9%) |
| Jun 2005 | - | $5.99M(+2.0%) |
| Mar 2005 | - | $5.87M(+4.7%) |
| Dec 2004 | $22.09M(+54.1%) | $5.61M(+0.7%) |
| Sep 2004 | - | $5.57M(+5.5%) |
| Jun 2004 | - | $5.27M(-6.5%) |
| Mar 2004 | - | $5.64M(+38.1%) |
| Dec 2003 | $14.33M(-23.4%) | $4.09M(+12.6%) |
| Sep 2003 | - | $3.63M(+3.2%) |
| Jun 2003 | - | $3.52M(+13.6%) |
| Mar 2003 | - | $3.10M(-10.8%) |
| Dec 2002 | $18.70M(+15.9%) | $3.47M(-9.3%) |
| Sep 2002 | - | $3.83M(-27.1%) |
| Jun 2002 | - | $5.25M(-14.7%) |
| Mar 2002 | - | $6.16M(+2.2%) |
| Dec 2001 | $16.14M(+22.8%) | $6.03M(+71.2%) |
| Sep 2001 | - | $3.52M(-1.7%) |
| Jun 2001 | - | $3.58M(+9.5%) |
| Mar 2001 | - | $3.27M(-15.3%) |
| Dec 2000 | $13.15M(+24.0%) | $3.86M(+40.5%) |
| Sep 2000 | - | $2.75M(-24.1%) |
| Jun 2000 | - | $3.62M(+21.6%) |
| Mar 2000 | - | $2.98M(+24.0%) |
| Dec 1999 | $10.60M(-14.5%) | $2.40M(-7.7%) |
| Sep 1999 | - | $2.60M(-3.7%) |
| Jun 1999 | - | $2.70M(-10.0%) |
| Mar 1999 | - | $3.00M(+36.4%) |
| Dec 1998 | $12.40M(-6.8%) | $2.20M(-38.9%) |
| Sep 1998 | - | $3.60M(+9.1%) |
| Jun 1998 | - | $3.30M(0.0%) |
| Mar 1998 | - | $3.30M(-2.9%) |
| Dec 1997 | $13.30M(+29.1%) | $3.40M(+17.2%) |
| Sep 1997 | - | $2.90M(-17.1%) |
| Jun 1997 | - | $3.50M(-2.8%) |
| Mar 1997 | - | $3.60M(+38.5%) |
| Dec 1996 | $10.30M(+10.8%) | $2.60M(-3.7%) |
| Sep 1996 | - | $2.70M(-10.0%) |
| Jun 1996 | - | $3.00M(+50.0%) |
| Mar 1996 | - | $2.00M(-16.7%) |
| Dec 1995 | $9.30M(+24.0%) | $2.40M(+9.1%) |
| Sep 1995 | - | $2.20M(+22.2%) |
| Jun 1995 | - | $1.80M(-41.9%) |
| Mar 1995 | - | $3.10M(+47.6%) |
| Dec 1994 | $7.50M | $2.10M(+10.5%) |
| Sep 1994 | - | $1.90M(-5.0%) |
| Jun 1994 | - | $2.00M(+25.0%) |
| Mar 1994 | - | $1.60M |
FAQ
- What is BioCryst Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual total expenses year-on-year change?
- What is BioCryst Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly total expenses year-on-year change?
What is BioCryst Pharmaceuticals annual total expenses?
The current annual total expenses of BCRX is $453.25M
What is the all time high annual total expenses for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual total expenses is $453.25M
What is BioCryst Pharmaceuticals annual total expenses year-on-year change?
Over the past year, BCRX annual total expenses has changed by +$18.13M (+4.17%)
What is BioCryst Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of BCRX is $124.31M
What is the all time high quarterly total expenses for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly total expenses is $136.07M
What is BioCryst Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, BCRX quarterly total expenses has changed by +$17.06M (+15.91%)